Duarte Irainsider trades
In SEC Form 4 filings, Duarte Ira is listed as EVP, Chief Financial Officer of Heron Therapeutics, Inc. /De/ (HRTX). Duarte Ira reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 21.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| HRTXHeron Therapeutics, Inc. /De/ | EVP, Chief Financial Officer | 3 | Oct 21 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| HRTXHeron Therapeutics, Inc. /De/ | Oct 19 | Oct 21 | M | 3,874 | not reported | not reported | 285,773 | No | Form 4 |
| HRTXHeron Therapeutics, Inc. /De/ | Oct 19 | Oct 21 | F | 1,102 | $0.36 | $397 | 284,671 | No | Form 4 |
| HRTXHeron Therapeutics, Inc. /De/ | Oct 19 | Oct 21 | M · derivative | 3,874 | $0.00 | $0 | 19,372 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.